Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Review the latest clinical data on novel approaches to extend the benefits of immunotherapy after disease progression in advanced NSCLC with downloadable slides and an interactive webcast from a live, expert-led roundtable webinar.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly